GSK delivers Q1 sales of £7.2 billion, -2% AER, +4% CER
Total EPS 11.2p, -48% AER, -33% CER; Adjusted EPS 24.6p, -2% AER, +11% CER
Read more - GSK delivers Q1 sales of £7.2 billion, -2% AER, +4% CER Read more
Total EPS 11.2p, -48% AER, -33% CER; Adjusted EPS 24.6p, -2% AER, +11% CER
Read more - GSK delivers Q1 sales of £7.2 billion, -2% AER, +4% CER Read more
Total EPS 31.4p, +67% AER, +36% CER; Adjusted EPS 111.8p, +11% AER, +4% CER
Read more - GSK delivers improvements in sales, margins and cash flow in 2017 Read more
Read more - GSK Consumer Healthcare appoints Filippo Lanzi as Head for Asia Pacific Read more
Read more - GSK opens new regional headquarters for Asia in Singapore Read more
Read more - GSK delivers Q3 sales of £7.8 billion, +4% AER, +2% CER Read more
Read more - GSK delivers further progress in Q2 and sets out new priorities for the Group Read more
Read more - Karenann Terrell appointed Chief Digital & Technology Officer, GSK Read more
The 2017 GSK Global Pain Index, commissioned by GSK Consumer Healthcare surveyed 19,000 adults across 32 countries including Singapore, examined the impact of body and head pain, from workplace productivity to relationships with family and friends.
Read more - Singaporeans’ pain costs economy USD 6.2 billion each year Read more